Bibliometric examination of neoadjuvant immunotherapy in esophageal cancer: insights, trends, collaborative networks, and prospective directions
In the future, we should continue to strengthen global cooperation in this field and further promote the development of large-scale phase III multicenter clinical trials. We need to establish standardized efficacy evaluation criteria and explore more clinically significant biomarkers.
Authors
- Haixia Wang (ORCID: https://orcid.org/0000-0002-5610-9641)
- Rongjian Xu (ORCID: https://orcid.org/0000-0001-7333-9193)
- Sheng Chen (ORCID: https://orcid.org/0000-0002-9428-3675)
- Min Zhao (ORCID: https://orcid.org/0000-0002-1263-5965)
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/jtd-2025-963
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00